Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 693

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 693
---
)Geographic information:
Year Ended December 31,
2024 2023 2022
───────────────────────────────────────────────────────────────────────────────────────────
(in US$ ’ 000)
Revenue from external customers:
PRC 452,413 484,895 426,409
US and Others 177,788 353,104 - 
630,201 837,999 426,409
December 31,
2024 2023
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
US and US and
PRC Others Total PRC Others Total
(in US$ ’ 000)
Total assets 1,212,722 61,474 1,274,196 1,252,957 26,816 1,279,773
Property, plant and equipment 91,849 649 92,498 98,809 918 99,727
Right-of-use assets 4,086 411 4,497 4,114 551 4,665
Leasehold land 10,706 - 10,706 11,261 - 11,261
Goodwill 2,990 - 2,990 3,064 - 3,064
Other intangible asset - - - 21 - 21
Investment in an equity investee 77,765 - 77,765 48,411 - 48,411
Investment in equity security 5,000 - 5,000 - - - 
(iii)Other information:
A summary of customers which accounted for over 10% of the Group’ s revenue for the years ended December 31, 2024, 2023 and 2022 is as follows:
Year Ended December 31,
2024 2023 2022
────────────────────────────────────────────────────────────────────
(in US$ ’ 000)
Customer A 177,789 353,104 (note)
Customer B 85,361 84,065 75,606
Customer C (note) (note) 51,681
Customer D (note) (note) 47,611
Note: Customer did not account for over 10% of the Group’s revenue during the year.
Customer A, B and C are included in Oncology/Immunology and Customer D is included in Other Ventures.

F-53

Table of Contents

27. Note to Consolidated